For the purposes of section 32A(4) of the Act, the prescribed particulars are the following—
(a) a statement by the approved analyst that they are an approved analyst within the meaning of section 32A(1) of the Act;
(b) a statement as to the method of analysis used;
(c) a statement that a substance that is, or is capable of being, a drug for the purposes of the Act was present in the urine sample analysed;
(d) the name of the substance found to be present in the urine sample analysed;
(e) the concentration of the substance found to be present in the urine sample analysed;
(f) the name and signature of the approved analyst;
(g) the date on which the analysis was conducted;
(h) a description of the contents of the identification label referred to in regulation 13(c) attached to the container in which the urine sample is placed.